Daniel M Miller
Overview
Explore the profile of Daniel M Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li M, Murphy M, Singh A, Aberle C, Miller D
Am J Health Syst Pharm
. 2024 Dec;
PMID: 39658065
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted...
2.
Ebert J, Shildkrot Y, Menezes A, Miller D
J Vitreoretin Dis
. 2023 Sep;
7(5):420-423.
PMID: 37706090
To describe the surgical technique and long-term outcomes of a modified split-thickness corneal patch grafting for conjunctival erosions that can be seen in patients with the Port Delivery System (PDS)...
3.
Okumura K, Latifi R, Smiley A, Lee J, Shnaydman I, Zangbar B, et al.
Surg Technol Int
. 2022 Aug;
41:85-93.
PMID: 36041078
Introduction: Using direct peritoneal resuscitation (DPR) as an adjunct when managing patients undergoing damage control laparotomy (DCL) shows promising results. We report our initial experience in utilizing DPR when managing...
4.
Dudenhoefer N, Noble C, Petersen M, Foster R, Riemann C, Sisk R, et al.
Retina
. 2022 Jul;
42(8):1568-1573.
PMID: 35877968
Purpose: To assess the long-term efficacy of intravitreal antivascular endothelial growth factor injections (IVI), alone or in combination with verteporfin photodynamic therapy (IVI/PDT), for management of choroidal neovascularization secondary to...
5.
Blankshain K, Snyder M, Miller D, Khatana A
J Cataract Refract Surg
. 2022 Mar;
48(4):502-503.
PMID: 35318294
No abstract available.
6.
Philip A, Wannamaker K, Miller D
Ophthalmic Epidemiol
. 2022 Jan;
30(1):82-87.
PMID: 35081852
Purpose: We describe a retrospective cohort study investigating the prevalence of pentosan polysulfate sodium (PPS) maculopathy in patients with PPS exposure, as well as the relationship between cumulative PPS exposure...
7.
Berger T, Manry M, Lindsell L, Osher J, Miller D, Foster R, et al.
Clin Ophthalmol
. 2021 Mar;
15:1133-1143.
PMID: 33758496
Purpose: To evaluate if off-label Age-Related Eye Disease Study 2 (AREDS2) supplementation prevents visual and anatomical deterioration in non-proliferative Idiopathic Macular Telangiectasia Type 2 (IMT2). Patients And Methods: This is...
8.
9.
Patel Y, Miller D, Fung A, Hill L, Rosenfeld P
Ophthalmol Retina
. 2019 Nov;
4(2):141-147.
PMID: 31735634
Purpose: To determine whether presence of macular hemorrhage on dilated fundus examination (DFE) or fundus photography influences vision outcomes with OCT-guided pro re nata (PRN) ranibizumab retreatment in patients with...
10.
Cebulla C, Stevenson W, Van Law H, Heisler-Taylor T, Hamadmad S, Shah M, et al.
Exp Eye Res
. 2019 May;
185:107667.
PMID: 31108057
No abstract available.